Senate Finance Committee Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) have unveiled their prescription drug pricing reform draft bill, "The Prescription Drug Pricing Reduction Act of 2019", with a Committee markup planned for Thursday, July 25. The draft bill has important PBM reforms, including discontinuing the use of PBM spread pricing in Medicaid Managed Care and a mandate requiring MCO pharmacy claim reimbursements be equal to a state Medicaid's fee-for-service claim payments. While the draft bill requires annual claim level DIR reporting to pharmacies, it does not include a mandate that DIR charges occur at point of sale, similar to S. 988, "Improving Transparency and Accuracy in Medicare Part D Spending Act."
This drug pricing reduction bill is important to pharmacy. During the July 25 markup, the Senate Finance Committee will consider amendments to the draft bill. Since one or both of your U.S. Senators serve on the Senate Finance Committee, you must contact them TODAY (roster and contact information here) by email or calling their Washington office and tell them:
- The Medicaid managed care prescription spread pricing prohibition provisions in the bill are important reforms to protect Medicaid patients, their pharmacies and taxpayers. It must remain in the bill.
- The Committee needs to protect Part D patients and their pharmacies by supporting an amendment to add the DIR Fix bill (S.988) to the Chairman's draft drug pricing reduction bill at the July 25 Committee markup.
This is our BEST chance to end retroactive DIRs; your Senators will decide if this happens.
Click here to contact your Senator on the Senate Finance Committee TODAY to Fix DIR.
Questions or Concerns? Contact IPC's Government Relations Team at: Government.Relations@ipcrx.com.